Filing Flows › Longevity Health Holdings (XAGE) › Q4 2025
Longevity Health Holdings (XAGE) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 31, 2026
Longevity Health Holdings (XAGE) reported revenue of $473K for the fourth quarter 2025 (Q4 2025), up 27-fold from a year earlier and +11% from the quarter before. Operating margin was -480.2%, net loss $2.1M (440.4% of revenue).
Longevity Health Holdings, Q4 2025: revenue $473K (27× year over year), operating margin -480.2%, net loss $2.1M, operating cash flow −$306K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $473K | +11% | 27× |
| Operating profit | −$2.3M | — | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$306K | — | — |
What changed
Revenue was $473K in Q4 2025, up 2606% year over year and up 11% from the previous quarter.
Gross margin was 56.6%, down 36.4 points from Q4 2024. Operating costs exceeded revenue by $2.3M, an operating margin of -480.2%. Operating expenses grew 148% against revenue growth of 2606%. The fastest-growing cost line was Sales & marketing (+477%). The quarter ended with a net loss of $2.1M, wider than the previous quarter's $1.4M loss.
Operating cash flow was −$306K. Non-cash charges added back $16K of depreciation and amortization and $194K of share-based compensation. Working capital and other items added $1.6M. Capital expenditures of $0K exceeded it, leaving free cash flow of −$306K.
Questions
What was Longevity Health Holdings' revenue in the fourth quarter 2025?
Longevity Health Holdings (XAGE) reported revenue of $473K for the fourth quarter 2025 (Q4 2025), up 27-fold from a year earlier and +11% from the quarter before.
Was Longevity Health Holdings profitable in the fourth quarter 2025?
Operating loss was $2.3M (-480.2% of revenue) and net loss $2.1M.